Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Pulmatrix, Inc. is a biopharmaceutical company specializing in inhaled therapies using its proprietary iSPERSE dry powder platform. It develops treatments for respiratory diseases and CNS disorders, including migraine, COPD, and ABPA. The company focuses on innovative drug delivery, aiming to improve efficacy and safety, and seeks strategic partnerships and monetization of its clinical assets in the global respiratory and neurological markets.
This description was generated via AI from an annual report. Updated about 1 year ago.